Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Friedman

Showing results (901-910 of 1,158) with videos related to

Pageof 116
Sort By:
American Journal of Public Health|February 24, 2001
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York CityT Diaz, D C Des Jarlais, D Vlahov, et al.
Drug and Alcohol Dependence|March 1, 2005
Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999Scott S Santibanez, Richard S Garfein, Andrea Swartzendruber, et al.
Current HIV Research|November 23, 2017
Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four YearsEvangelia Kostaki, Gkikas Magiorkinis, Mina Psichogiou, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use DrugsAshley L Buchanan, Natallia Katenka, Youjin Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
High Variation in Purity of Consumer-Level Illicit Fentanyl Samples in Los Angeles, 2023-2025Chelsea L Shover, Adam J Koncsol, Morgan E Godvin, et al.
Frontiers in Microbiology|September 11, 2018
Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, GreeceLeslie D Williams, Evangelia-Georgia Kostaki, Eirini Pavlitina, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trialsD C Des Jarlais, S Vanichseni, M Marmor, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2019
Capsaicinoids: Multiple effects on angiogenesis, invasion and metastasis in human cancersJamie R Friedman, Stephen D Richbart, Justin C Merritt, et al.
Current HIV/AIDS Reports|June 23, 2018
Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV PreventionPedro Mateu-Gelabert, H Guarino, K Quinn, et al.
Pageof 116

Showing results (901-910 of 1,158) with videos related to

Sort By:
Pageof 116
American Journal of Public Health|February 24, 2001
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York CityT Diaz, D C Des Jarlais, D Vlahov, et al.
Drug and Alcohol Dependence|March 1, 2005
Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999Scott S Santibanez, Richard S Garfein, Andrea Swartzendruber, et al.
Current HIV Research|November 23, 2017
Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four YearsEvangelia Kostaki, Gkikas Magiorkinis, Mina Psichogiou, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use DrugsAshley L Buchanan, Natallia Katenka, Youjin Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
High Variation in Purity of Consumer-Level Illicit Fentanyl Samples in Los Angeles, 2023-2025Chelsea L Shover, Adam J Koncsol, Morgan E Godvin, et al.
Frontiers in Microbiology|September 11, 2018
Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, GreeceLeslie D Williams, Evangelia-Georgia Kostaki, Eirini Pavlitina, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trialsD C Des Jarlais, S Vanichseni, M Marmor, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2019
Capsaicinoids: Multiple effects on angiogenesis, invasion and metastasis in human cancersJamie R Friedman, Stephen D Richbart, Justin C Merritt, et al.
Current HIV/AIDS Reports|June 23, 2018
Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV PreventionPedro Mateu-Gelabert, H Guarino, K Quinn, et al.
Pageof 116